Insider Trading & Ownership - Oncotelic Therapeutics Inc. (OTLC)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Oncotelic Therapeutics Inc.
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2025-01-29
Purchase		 2025-01-31
5:08 pm		 Oncotelic Therapeutics Inc. OTLC Trieu Vuong
CHAIRMAN AND CEO
10% Owner		 346,844 $0.028 $9,712 116,842,473
(Indirect
Direct)		 View
2024-11-22
Purchase		 2024-11-26
11:33 am		 Oncotelic Therapeutics Inc. OTLC Trieu Vuong
CHAIRMAN AND CEO
10% Owner		 298,499 $0.0289 $8,627 116,495,629
(Indirect
Direct)		 View
2024-08-23
Purchase		 2024-08-27
08:00 am		 Oncotelic Therapeutics Inc. OTLC Trieu Vuong
CHAIRMAN AND CEO
10% Owner		 500,000 $0.02 $10,000 116,197,130
(Indirect
Direct)		 View
2023-06-28
Purchase		 2023-06-30
09:25 am		 Oncotelic Therapeutics Inc. OTLC Trieu Vuong
CHAIRMAN AND CEO
10% Owner		 500,000 $0.02175 $10,875 115,272,130
(Indirect
Direct)		 View
2023-06-16
Purchase		 2023-06-20
12:00 pm		 Oncotelic Therapeutics Inc. OTLC Trieu Vuong
CHAIRMAN AND CEO
10% Owner		 100,000 $0.026 $2,600 115,197,130
(Indirect
Direct)		 View
2023-06-14
Purchase		 2023-06-16
12:00 pm		 Oncotelic Therapeutics Inc. OTLC Trieu Vuong
CHAIRMAN AND CEO
10% Owner		 400,000 $0.0326 $13,040 115,097,130
(Indirect
Direct)		 View
2023-05-26
Purchase		 2023-05-31
09:39 am		 Oncotelic Therapeutics Inc. OTLC Trieu Vuong
CHAIRMAN AND CEO
10% Owner		 126,888 $0.0341 $4,327 114,697,130
(Indirect
Direct)		 View
2023-05-02
Purchase		 2023-05-02
5:00 pm		 Oncotelic Therapeutics Inc. OTLC Trieu Vuong
CHAIRMAN AND CEO
10% Owner		 100,000 $0.045 $4,500 114,570,242
(Indirect
Direct)		 View
2022-12-06
Purchase		 2022-12-07
08:00 am		 Oncotelic Therapeutics Inc. OTLC Trieu Vuong
CHAIRMAN AND CEO
10% Owner		 120,000 $0.05 $6,000 114,210,934
(Indirect
Direct)		 View
2022-11-22
Purchase		 2022-11-25
09:00 am		 Oncotelic Therapeutics Inc. OTLC Trieu Vuong
CHAIRMAN AND CEO
10% Owner		 70,000 $0.08 $5,600 114,090,934
(Indirect
Direct)		 View
2022-09-26
Purchase		 2022-09-28
09:15 am		 Oncotelic Therapeutics Inc. OTLC Trieu Vuong
CHAIRMAN AND CEO
10% Owner		 20,000 $0.068 $1,360 114,020,934
(Indirect
Direct)		 View
2022-08-25
Purchase		 2022-08-29
09:15 am		 Oncotelic Therapeutics Inc. OTLC Trieu Vuong
CHAIRMAN AND CEO
10% Owner		 80,000 $0.082 $6,560 114,000,934
(Indirect
Direct)		 View
2020-11-20
Purchase		 2020-11-24
5:30 pm		 MATEON THERAPEUTICS INC MATN Shah Amit B.
CHIEF FINANCIAL OFFICER		 60,000 $0.19264 $11,558 60,000
(Direct)		 View
2020-11-19
Purchase		 2020-11-23
3:01 pm		 MATEON THERAPEUTICS INC MATN Park Chulho
CHIEF TECHNOLOGY OFFICER		 22,173 $0.1848 $4,098 2,833,992
(Direct)		 View
2020-11-19
Purchase		 2020-11-23
3:01 pm		 MATEON THERAPEUTICS INC MATN Trieu Vuong
CHIEF EXECUTIVE OFFICER		 50,500 $0.19 $9,595 19,944,035
(Indirect
Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2021-09-03
Option Award		 2021-09-08
5:00 pm		 N/A
2031-09-03		 Oncotelic Therapeutics Inc. OTLC Trieu Vuong
Chief Executive Officer		 225,000 $0 225,000
(Direct)		 View
2021-09-03
Option Award		 2021-09-08
5:00 pm		 N/A
2031-09-03		 Oncotelic Therapeutics Inc. OTLC MAIDA ANTHONY E III
Chief Clin. Ops. Officer		 600,000 $0 600,000
(Direct)		 View
2021-09-03
Option Award		 2021-09-08
5:00 pm		 N/A
2031-09-03		 Oncotelic Therapeutics Inc. OTLC KING STEVEN W
Director		 500,000 $0 500,000
(Direct)		 View
2021-09-03
Option Award		 2021-09-08
5:00 pm		 N/A
2031-09-03		 Oncotelic Therapeutics Inc. OTLC Saund Saran
Chief Business Officer		 675,000 $0 675,000
(Direct)		 View
2021-07-08
Option Award		 2021-07-16
5:39 pm		 2021-07-08
2031-07-08		 Oncotelic Therapeutics Inc. OTLC MAIDA ANTHONY E III
CHIEF CLINICAL OFFICER		 400,000 $0 1,537,314
(Direct)		 View
2021-03-31
Conversion		 2021-07-16
5:39 pm		 N/A
N/A		 Oncotelic Therapeutics Inc. OTLC MAIDA ANTHONY E III
CHIEF CLINICAL OFFICER		 939,584 $0 1,537,314
(Direct)		 View
2021-07-08
Option Award		 2021-07-16
5:38 pm		 2021-07-08
2031-07-08		 Oncotelic Therapeutics Inc. OTLC Trieu Vuong
CHAIRMAN AND CEO
10% Owner		 773,255 $0 97,913,805
(Direct)		 View
2021-03-31
Conversion		 2021-07-16
5:38 pm		 N/A
N/A		 Oncotelic Therapeutics Inc. OTLC Trieu Vuong
CHAIRMAN AND CEO
10% Owner		 94,070,882 $0 97,913,805
(Direct)		 View
2021-07-08
Option Award		 2021-07-16
5:37 pm		 2021-07-08
2031-07-08		 Oncotelic Therapeutics Inc. OTLC KING STEVEN W
Director		 357,412 $0 3,688,059
(Direct)		 View
2021-03-31
Conversion		 2021-07-16
5:37 pm		 N/A
N/A		 Oncotelic Therapeutics Inc. OTLC KING STEVEN W
Director		 3,295,012 $0 3,688,059
(Indirect)		 View
2021-07-08
Option Award		 2021-07-16
5:37 pm		 2021-07-08
2031-07-08		 Oncotelic Therapeutics Inc. OTLC Shah Amit B.
CHIEF FINANCIAL OFFICER		 997,093 $0 1,057,093
(Direct)		 View
2021-07-08
Option Award		 2021-07-16
5:36 pm		 2021-07-08
2031-07-08		 Oncotelic Therapeutics Inc. OTLC Diamond David
Director		 451,467 $0 451,467
(Direct)		 View
2021-07-08
Option Award		 2021-07-16
5:35 pm		 2021-07-08
2031-07-08		 Oncotelic Therapeutics Inc. OTLC Saund Saran
CHIEF BUSINESS OFFICER		 318,798 $0 16,673,759
(Direct)		 View
2021-03-31
Conversion		 2021-07-16
5:35 pm		 N/A
N/A		 Oncotelic Therapeutics Inc. OTLC Saund Saran
CHIEF BUSINESS OFFICER		 16,371,316 $0 16,673,759
(Direct)		 View

Ownership		 2020-05-21
8:29 pm		 N/A
N/A		 MATEON THERAPEUTICS INC MATN MAIDA ANTHONY E III
Director		 0 $0 1,137,314
(Direct)		 View

Ownership		 2020-05-21
8:27 pm		 N/A
N/A		 MATEON THERAPEUTICS INC MATN KING STEVEN W
Director		 0 $0 4,618,424
(Direct)		 View